It could also efficiently induce ubiquitinproteasomal degradation of BRD4 in AR-positive prostate cancer cell lines, with sub-nanomolar half-maximal degradation concentrations (DC50) and maximum degradation (Dmax) > 99%. The gene discussed is AR; the disease is prostate carcinoma.